NCT06711185View on ClinicalTrials.gov

Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

August 30, 2026

Conditions
Breast Cancer
Interventions
DRUG

Dapagliflozin 10 mg

Patients in this group will receive 1 tablet of 10mg dapagliflozin daily for 9 months, starting 7-10 days before chemotherapy treatment.

OTHER

Placebo

Patients in this group will receive 1 placebo tablet per day, with identical characteristics to the group receiving dapagliflozin, for 9 months, starting 7-10 days before the start of chemotherapy treatment

Trial Locations (1)

13083-888

RECRUITING

Hospital de Clinicas da Unicamp, Campinas

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER